Featured Research

from universities, journals, and other organizations

Global view of how HIV/AIDS hijacks cells during infection

Date:
December 31, 2011
Source:
Gladstone Institutes
Summary:
Scientists have identified how HIV -- the virus that causes AIDS -- hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic.

Gladstone Institutes scientist Nevan Krogan, PhD, has identified how HIV -- the virus that causes AIDS -- hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic.

Dr. Krogan conducted this research in his laboratory at the University of California, San Francisco (UCSF) -- a leading medical school with which Gladstone is affiliated -- where Dr. Krogan is an associate professor of cellular and molecular pharmacology and an affiliate of the California Institute for Quantitative Biosciences (QB3). Since joining Gladstone as an associate investigator in June, Dr. Krogan has served as a unique, collaborative bridge between the two institutions in the field of systems biology, an area in which scientists perform advanced, computational analysis of large-scale data sets that are drawn from complex biological systems.

In his companion papers being published online in Nature, Dr. Krogan describes how HIV commandeers restriction factors -- a class of human proteins that have evolved to block viruses such as HIV -- to weaken the body's defenses and enhance the virulence of HIV infection.

"One of the keys to HIV's success is how quickly it can evolve new attack strategies -- and the way in which it uses our own proteins against us is a prime example of that," said Dr. Krogan. "However, now that we've shed light on this complex process, we are one step closer to developing new drugs that will help us pull ahead in this evolutionary arms race."

AIDS has killed more than 25 million people around the world since first being identified some 30 years ago. In the United States alone, more than one million people live with HIV/AIDS at an annual cost of $34 billion. Dr. Krogan's experiments show promise for the development of more effective antiretroviral therapies for people with HIV. Further, they have laid the foundation for future research at Gladstone.

In his experiments, Dr. Krogan performed a two-part investigation of protein interactions. First, he conducted a systematic, global analysis of all potential interactions that occur between proteins made by the body (human proteins) and proteins made by the virus (HIV proteins). Second, he whittled down these ~500 interactions to the one that appeared most likely to fuel HIV infection: the interaction between the human protein CBFβ and the HIV protein Vif.

Normally during HIV infection, a restriction factor called APOBEC3G acts as a molecular roadblock, preventing the virus from reaching its target -- the CD4 T white blood cells that are a major component of the immune system. But Dr. Krogan found that when the HIV protein Vif binds to the human protein CBFβ, Vif is strengthened and APOBEC3G degrades. This degradation weakens ABOBEC3G's ability to stop HIV and the virus is free to infect the CD4 T cells.

"This is the first comprehensive look at how HIV interacts globally with components of the cell," said Judith H. Greenberg, PhD, acting director of the National Institutes of Health's National Institute of General Medical Sciences, which partially supported this research through its AIDS-related structural biology program. "The work is a good example of how biophysical studies can improve our understanding of disease and point the way to the exploration of potential therapeutic targets."

Other groups at UCSF who participated in this research include the labs of John Gross, PhD, Andrej Sali, PhD, Alan Frankel, PhD, Alma Burlingame, PhD, Charles Craik, PhD, Ryan Hernandez, PhD, and Tanja Kortemme. Funding came from a wide variety of sources, including QB3, the Host Pathogen Circuitry Center at UCSF, the Searle Scholars Program, the W.M. Keck Foundation and the National Institutes of Health.


Story Source:

The above story is based on materials provided by Gladstone Institutes. Note: Materials may be edited for content and length.


Journal References:

  1. Stefanie Jδger, Peter Cimermancic, Natali Gulbahce, Jeffrey R. Johnson, Kathryn E. McGovern, Starlynn C. Clarke, Michael Shales, Gaelle Mercenne, Lars Pache, Kathy Li, Hilda Hernandez, Gwendolyn M. Jang, Shoshannah L. Roth, Eyal Akiva, John Marlett, Melanie Stephens, Ivan D’Orso, Jason Fernandes, Marie Fahey, Cathal Mahon, Anthony J. O’Donoghue, Aleksandar Todorovic, John H. Morris, David A. Maltby, Tom Alber, Gerard Cagney, Frederic D. Bushman, John A. Young, Sumit K. Chanda, Wesley I. Sundquist, Tanja Kortemme, Ryan D. Hernandez, Charles S. Craik, Alma Burlingame, Andrej Sali, Alan D. Frankel, Nevan J. Krogan. Global landscape of HIV–human protein complexes. Nature, 2011; DOI: 10.1038/nature10719
  2. Stefanie Jδger, Dong Young Kim, Judd F. Hultquist, Keisuke Shindo, Rebecca S. LaRue, Eunju Kwon, Ming Li, Brett D. Anderson, Linda Yen, David Stanley, Cathal Mahon, Joshua Kane, Kathy Franks-Skiba, Peter Cimermancic, Alma Burlingame, Andrej Sali, Charles S. Craik, Reuben S. Harris, John D. Gross, Nevan J. Krogan. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature, 2011; DOI: 10.1038/nature10693

Cite This Page:

Gladstone Institutes. "Global view of how HIV/AIDS hijacks cells during infection." ScienceDaily. ScienceDaily, 31 December 2011. <www.sciencedaily.com/releases/2011/12/111221140351.htm>.
Gladstone Institutes. (2011, December 31). Global view of how HIV/AIDS hijacks cells during infection. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/12/111221140351.htm
Gladstone Institutes. "Global view of how HIV/AIDS hijacks cells during infection." ScienceDaily. www.sciencedaily.com/releases/2011/12/111221140351.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins